Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
TEAS Plus Application
Serial Number:88132087
Filing Date:09/26/2018
NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular
application.
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
TEAS Plus Application
Serial Number:88132087
Filing Date:09/26/2018
To the Commissioner for Trademarks:
MARK: VAXNEUVANCE (Standard Characters, see mark)
The mark in your application is VAXNEUVANCE.
The applicant, Merck Sharp & Dohme Corp., a corporation of New Jersey, having an address of
One Merck Drive
Whitehouse Station, New Jersey 08889
United States
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
For specific filing basis information for each item, you must view the display within the Input Table.
International Class 005: Human vaccine preparations
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services. (15 U.S.C. Section 1051(b)).
The applicant's current Attorney Information:
James A. Thomas and Lisa Jakob, Amy C. Van Eepoel of Merck & Co., Inc.
Office of General Counsel
126 E. Lincoln Avenue
Rahway, New Jersey 07065
United States
732-594-1767(phone)
732-594-5760(fax)
james.thomas2@merck.com (authorized)
The applicant's current Correspondence Information:
James A. Thomas
Merck & Co., Inc.
Office of General Counsel
126 E. Lincoln Avenue
Rahway, New Jersey 07065
732-594-1767(phone)
732-594-5760(fax)
TrademarkUS@merck.com;james.thomas2@merck.com; lynn.brumfield@merck.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant or the applicant's attorney, or the applicant's domestic representative at
the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Plus status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $225 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /Jeremy Sowers/ Date: 09/25/2018
Signatory's Name: Jeremy Sowers
Signatory's Position: Director, Global Marketing
Signatory's Phone Number: 000-000-0000
Payment Sale Number: 88132087
Payment Accounting Date: 09/26/2018
Serial Number: 88132087
Internet Transmission Date: Wed Sep 26 10:23:49 EDT 2018
TEAS Stamp: USPTO/FTK-XXX.XX.XX.XXX-2018092610234940
5165-88132087-6103d42cd451ddeae2b7486cb8
5049fa3cb9dc6cafd1a29add7a7f17852a2bd092
-DA-8941-20180920090029880666